All news

CRA International adds life sciences VP Hillan

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

CRA International appointed Patrick Hillan as Vice President for Life Sciences Commercial Strategy, deepening its leadership bench in a key sector. The move follows a second-quarter revenue beat, with the company reporting USD 210.81 million against an expected USD 198.91 million. Analysts maintain a Moderate Buy rating, with a target price significantly above the current stock value, citing recent performance and strategic growth in life sciences.

Read original source

CRAI company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.